secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model (transgenic Drosophila) without human data
PubMed 28165856 · doi:10.1080/19336934.2017.1291104
What was done
Researchers generated PhiC31-based transgenic Drosophila lines expressing human heat shock proteins (Hsp27, Hsp40, Hsp60, and Hsp70) and evaluated their comparative ability to protect against toxicity caused by extracellular amyloid-β42 (Aβ42) peptide deposition.
What was found
No quantitative data or effect sizes are provided in the abstract. The authors report qualitatively that only secreted Hsp70 (secHsp70) exhibited robust protection against extracellular Aβ42-induced toxicity, whereas other tested heat shock proteins did not.
Why it matters
The study suggests that extracellular neuroprotection against Aβ42 is uniquely mediated by secHsp70 among the tested chaperones, proposing engineered secreted chaperones as a potential strategy for targeting extracellular amyloids.
Limits
The study was conducted entirely in transgenic Drosophila models, with no mammalian or human validation. The abstract lacks sample sizes, quantitative measurements, statistical analyses, and specific mechanistic details.
Cited by
- supports In animal models, heat shock proteins protect against the aggregation of amyloid-beta 42 associated with Alzheimer's disease.